Authors


Ravi N. Shah, MD, MBA

Latest:

Technology-Enabled Care: The Future of Our Field

What will psychiatric practice look like in the year 2030?


Bethany Hughes, MD

Latest:

Insights From the 2022 AAPL Annual Meeting

The American Academy of Psychiatry and the Law hosted its first in-person meeting in October 2022. Check out these highlights.


Laura Jana, MD

Latest:

Let’s Build Brains Better! Brain Science-Inspired Policies for the Future

In order to face the rapidly changing, increasingly complex, and globally connected world, we need to focus on the importance of early brain and child development.


Jaya Jaya Myra

Latest:

Holiday Foods to Boost Willpower

What can you put on your plate this holiday season to keep your body and mind healthy?


F. Gerard Moeller, MD

Latest:

Beyond Abstinence: Other Clinically Meaningful Endpoints for Patients With Substance Use Disorders

While complete abstinence is a good goal, what other clinically meaningful endpoints are there for patients with substance use disorders? Learn more in this ACNP 2024 Annual Meeting session!


Liz Irvin

Latest:

2 True Stories

Medical student Liz Irvin discusses how storytelling is integral to her ability to stay sensitive when it comes to medicine and education, and shares a poem about an experience she had caring for others before starting medical school.



Andrew Troy Hodge, MD

Latest:

Exploring Diagnostic Strategies in the Assessment of Mixed Affective States

In this CME article, examine how current DSM nosology defines the proper method of assessing a mixed-episode patient and which diagnostic labels to give them based on their presenting symptomatology.


Jeffrey L. Cummings, MD, ScD

Latest:

Advancing Brain Capital: Achievements, Lessons, and Next Steps

A transdisciplinary team summarizes key points and reflections after 18 months of activity.


Robert M. Lundin, BSc, MBBCh

Latest:

Telling Humanity’s Brain Story: Insights From Brain Capital

Which innovations can improve measurement, technology, investment, and public policy surrounding brain health?


Stephanie Galaitsi, MSEE

Latest:

Resilience and Healthy Aging

What does 'resilience' include for older adults?


Quinn MacDougald, MD

Latest:

History of Psychiatry: Its Relevance in Training and Beyond

Here are 5 reasons why we need to study the history of psychiatry.


Lindsey Pinto, LSW, MSW

Latest:

Recovery-Oriented Cognitive Therapy: A Game Changer for Justice-Involved Individuals

"CT-R emphasizes the importance of hope while taking it a step further, turning hope into meaningful action and internalizing what success says about a person’s identity, strength, and ability to navigate future challenges."


Amy Emerson
Amy Emerson

Latest:

MDMA-Assisted Therapy for PTSD: A Conversation With Amy Emerson, CEO of Lykos Therapeutics

If approved, how will MDMA-assisted therapy impact clinical psychiatry? The CEO of Lykos Therapeutics shares her thoughts.


Aaron Mack, MD

Latest:

Recognizing the Contributions and the Struggles of Black Psychiatrists

“It is of the utmost importance to provide culturally competent forensic psychiatric services that are better suited to the needs of the African American community.”


Justin S. Tauscher, PhD

Latest:

Integrating Digital Therapeutics Into Care of Serious Mental Illness

How can digital therapeutics more readily be brought into the hands of patients with serious mental illnesses?


Carmen Kosicek, MSN, PMHNP-BC

Latest:

Supporting Mothers With Postpartum Depression and Promoting Culturally Sensitive Care

Panelists discuss how faster-acting treatments like zuranolone might improve patient outcomes and quality of life, the initial signs to monitor for assessing effectiveness, barriers to accessing such therapies in underserved populations and strategies to increase accessibility, approaches to ensuring safety while addressing distress in patients with intrusive thoughts, effective strategies for managing sleep issues in postpartum depression (PPD), advice for the psychiatry community when treating PPD, and how to tailor advice for clinicians working with underserved populations.


Brent Masel, MD

Latest:

Clinical Pearls: Inside the Mind of the Athlete

With the Super Bowl highlighting elite athletic performance, sports psychiatry is essential in strengthening athletes' mental resilience and well-being.


Douglas W. Heinrichs, MD

Latest:

Medical Aid in Dying and the “Slippery Slope” Argument

An expert offers a critical examination of the "slippery slope" argument.


Amit Etkin, MD, PhD

Latest:

Alto Neuroscience Presents Key Data, Study Findings on ALTO-300

Learn more about Alto Neuroscience's ALTO-300, in ongoing phase 2b trials as an adjunct treatment for major depressive disorder.


Ekta Patel, PhD

Latest:

Driving Advances in Drug Discovery for Mental Health Conditions

Understanding and addressing the unmet therapeutic needs of individuals living with mental health conditions.


Jun Park

Latest:

Dietary Interventions for ADHD: Emerging Research and Considerations

What is the connection between ADHD diagnosis and a Western dietary pattern?


Warren Y.K. Ng, MD, MPH

Latest:

The Urgent Need to Address Youth Mental Health

In this 2-part Special Report, we highlight the urgency of addressing child and adolescent mental health.


Alejandro Alva, MD

Latest:

The Cutting Edge of Medicine: An Interview With Alejandro Alva, MD

In advance of the June 4 FDA Advisory Committee Meeting on MDMA-assisted therapy, we sat down with Alejandra Alva, MD, to get his first impressions.


Rosemary Kennedy, PhD

Latest:

The Role of Technology in Addressing Isolation of Older Adults

Seniors living independently have suffered isolation during the pandemic. What role can technology play in solving this?


Sarah J. Getz, PhD

Latest:

Vulnerability to Financial Scamming: Victim and Family Protection

With the growing elderly population and the prevalence of cognitive impairment, how can we protect older adults from financial scams?


Victor Ajluni, MD

Latest:

Cannabis and Schizophrenia: Implications in the Legalization Era

A look at the association between cannabis use and schizophrenia, as well as the need for comprehensive public health policies and education.


Marie Anne Gebara, MD

Latest:

Augmentation Strategies for Treatment-Resistant Depression

Given that two-thirds of patients treated for a major depressive episode will fail to achieve remission of symptoms after 2 or more treatment trials of first-line antidepressants, the probability of remission will further decrease with subsequent medication trials. Treatment strategies for patients with TRD include augmentation, where a medication is added to a current antidepressant versus switching to a different antidepressant.


Alan Schwartz, MD

Latest:

Psychiatrists Call for End to Cruel and Harmful Immigration Policy

The Group for the Advancement of Psychiatry (America’s mental health think tank) calls for an end to the use of Title 42 to expel asylum seekers at the southern border. This policy places LGBTIQ asylum seekers in particular danger.


Robin M. Johnson, MD

Latest:

The Vanishing White Coat

If Roe v Wade is overturned, how will patients with serious mental illness be affected?

© 2025 MJH Life Sciences

All rights reserved.